KVUE Company Profile and Key Details

Q: Who are the executives of KVUE?

Ms. Kathleen M. WidmerGroup Pres of North America & Latin AmericaMs. Ellie Bing XieGroup Pres of Asia PacificMs. Meredith StevensChief Operations OfficerMs. Heather R. HowlettChief Accounting OfficerMr. Bernardo TavaresChief Data & Technology OfficerDr. Caroline TillettChief Scientific OfficerMr. Matthew OrlandoGen. CounselMr. Paul RuhChief Financial OfficerMr. Carlton LawsonGroup Pres of Europe, Middle East & Africa

NYSE : KVUE

Kenvue

$17.75

-0.64-3.48%

At Close 4:00 PM

Profile Key Stats Analyst Ratings Ownership Ratios Financials Dividend & splits Sentiment Forecast

Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.

Stocks Telegraph does not provide any advice or recommendations for buying or selling stocks, securities, or other financial products. Information contained on this website is for informational purposes only and should not be construed as professional financial, investment or other advice. Stocks Telegraph is not liable for any loss or damage that may occur as a result of reliance on this data.

Price Chart

Stock Price Today

Kenvue Inc. (KVUE) stock declined over -3.48%, trading at $17.75 on NYSE, down from the previous close of $18.39. The stock opened at $18.14, fluctuating between $17.67 and $18.23 in the recent session.

Stock Snapshot

18.39

Prev. Close

34.08B

Market Cap

17.67

Day Low

15.04

P/E Ratio

1.18

EPS (TTM)

1.41

Cash Flow per Share

18.14

Open

1.92B

Number of Shares

18.23

Day High

99.85%

Free Float in %

5.85

Book Value

22.52M

Volume

Relevant Articles

SEC Fillings

Current Report (8-k)

Filing Date	Accepted Date

Annual Report (10-k)

Filing Date	Accepted Date

Stock Price History Chart

Date	Open	High	Low	Close	Volume
Sep 09, 2026	18.23	18.23	17.67	17.75	22.52M
Sep 08, 2026	18.63	18.65	18.38	18.39	16.22M
Sep 04, 2026	18.85	18.98	18.69	18.74	26.75M
Sep 03, 2026	19.18	19.18	18.84	18.95	18.16M
Sep 02, 2026	18.76	19.14	18.75	19.13	19.1M
Sep 01, 2026	18.90	19.03	18.71	18.75	21.75M
Aug 31, 2026	19.05	19.10	18.83	18.88	26.88M
Aug 28, 2026	19.26	19.39	19.13	19.17	11.89M
Aug 27, 2026	19.04	19.25	18.99	19.20	14.39M
Aug 26, 2026	19.42	19.47	19.21	19.22	25.4M
Aug 25, 2026	19.28	19.38	19.18	19.33	20.41M
Aug 24, 2026	19.10	19.56	19.10	19.43	16.1M
Aug 21, 2026	18.97	19.16	18.87	19.06	13.55M
Aug 20, 2026	19.04	19.16	18.87	18.93	17.23M
Aug 19, 2026	18.91	19.18	18.88	19.13	27.35M
Aug 18, 2026	19.00	19.12	18.80	18.80	25.5M
Aug 17, 2026	19.04	19.04	18.74	18.79	19.43M
Aug 14, 2026	19.19	19.31	19.13	19.20	9.79M
Aug 13, 2026	19.02	19.29	19.02	19.20	16.99M
Aug 12, 2026	18.69	19.06	18.65	18.98	11.02M

Contact Details

Summit, NJ 07901

United States

https://www.kenvue.com 908 874 1200

About Company

Kenvue Inc. functions as a global leader in the consumer health sector. The company structures its operations across three primary divisions: Self Care, Skin Health and Beauty, and Essential Health. Within the Self Care unit, it offers a diverse range of products for common conditions like coughs, colds, and allergies, in addition to pain relief, digestive health, and smoking cessation aids, featuring prominent brands such as Tylenol, Nicorette, and Zyrtec. The Skin Health and Beauty segment delivers various solutions for facial, body, hair, and sun protection, recognized under popular labels including Neutrogena, Aveeno, and OGX. Moreover, the Essential Health category provides oral hygiene, infant care, feminine wellness, and wound treatment products, marketed through esteemed brands like Listerine, Johnson's, Band-Aid, and Stayfree. Established in 2022, Kenvue Inc. maintains its corporate headquarters in Skillman, New Jersey, and operates as a subsidiary of Johnson & Johnson.

Stock Peers

-2.94-2.02%

The Procter & Gamble Company$142.64 ELF

-4.23-4.06%

e.l.f. Beauty, Inc.$100.08 EL

-2.92-2.87%

The Estée Lauder Companies Inc.$98.77 CHD

-1.34-1.39%

Church & Dwight Co., Inc.$95.20 CLX

-1.98-2.16%

The Clorox Company$89.62 CL

-0.38-0.43%

Colgate-Palmolive Company$88.03 SPB

-1.83-2.09%

Spectrum Brands Holdings, Inc.$85.65 UL

-1.05-1.65%

Unilever PLC$62.49 EPC

-0.62-2.24%

Edgewell Personal Care Company$27.09 USNA

-0.08-0.53%

USANA Health Sciences, Inc.$15.12

Company Overview

Kenvue Inc. (NYSE:KVUE) closed at $17.75 USD, losing -$0.64 (-3.48%) from the previous close of $18.39. The stock is currently mid-range between its 52-week high and low $14.02 and $20.13. With a market capitalization of about $34.08 billion, Kenvue Inc. is classified as a large-cap and shows lower-than-market volatility (beta ~0.43). Key stats such as the average daily volume over the past year has been around 20.50 million shares, in line with its 52-week average. Headquartered in Summit, NJ, Kenvue Inc. operates in the Consumer Defensive sector and the Household & Personal Products industry. Led by CEO Kirk L. Perry, the company employs approximately 21,890 people and listed since May 04, 2023. Kenvue Inc. functions as a global leader in the consumer health sector.

Technical Performance

KVUE has shown sold momentum, gaining 3.47% over the past week and 15.04% over the past quarter, though year-to-date performance is up 1.97%. Short-term trend indicators are mixed aligned (SMA20 3.69%, SMA50 7.64%, SMA200 0.16%). The stock’s 14-day RSI is 66.65 (firm momentum), while the ATR of 0.36 points to higher daily volatility. The stock remains hovering near 52-week lows, trading -24.51% below its high and over 35.52% above its low. Average 10-day trading volume of 21.63 million shares is slightly above the 3-month average of 19.27 million, indicating heightened recent market interest.

Valuation Metrics

Kenvue Inc. trades at a P/E ratio of 20.44, slightly below the S&P 500 average, with a price-to-sales ratio of 2.22 and a price-to-book ratio of 3.24 trading at moderately above to book value. The P/FCF stands at 16.13, also above market averages.

Dividend & Fair Value

Kenvue Inc. last paid a dividend of 0.83 per share, Dividend and splits history remains an important factor for investors monitoring long-term returns. A discounted cash flow model estimates fair value at around $46.39. This means the shares are trading below this model’s fair value.

Earnings & Analyst Outlook

Wall Street analysts project EPS growth of 5.66% annually over the next five years. The latest quarter delivered EPS of $0.31. The next quarter is forecast at $0.26. Next year's EPS is expected at $0.47. Analyst sentiment is neutral. Analyst rating data shows there are 1 Strong Buy ratings, 3 Buy ratings, 18 Hold ratings, 0 Sell rating and 0 Strong Sell ratings. Price targets range from $23.00 to $15.00. The high target offers 29.58% upside. The low target suggests -15.49% downside. The mean target is $18.91. This offers 6.54% upside. Kenvue Inc. earnings surprise history is a consistent trend of beating forecasts. The quarter that ended August 06, 2026, missed forecasts by -2.76%. The prior quarter beat by 18.52%. Over the last six quarters, Apple has recorded several small beats. These include 5.49% in May 08, 2025.

Shareholding & Insider Activity

Kenvue Inc. has 1.92 billion shares outstanding. The public float is 1.92 billion shares, elevated short interest at 2.52% of float. This equals 36.45 million shares. The short ratio is 1.97 days. Institutional investors hold 94.97% of the float. Insiders own 0.05%. Smith Jeffrey C holds 27.31 million shares, Lawson Carlton has 56.32 thousand shares and Howlett Heather has 29.29 thousand shares. Over the past six months, insider transactions show net selling. They sold 42.19 thousand shares across 2 transactions.

Financial & Profitability Overview

Over the trailing twelve months, Kenvue generated $15.44B in revenue, or $8.06 per share. Gross margin was 55.77%, operating margin 19.03%, and net profit margin 10.78%. Returns are healthy, with ROA at 5.97% and ROE at 14.84%.
On valuation metrics, Kenvue trades at a P/E of 20.44, P/S of 2.22 and P/B of 3.24. The current ratio is 1.01 and quick ratio is 0.71. Operationally, the company’s inventory turnover is 3.74 and cash conversion cycle is 20.87 days. Debt-to-equity is 0.80, supported by a cash flow-to-debt ratio of 0.27.

Quarterly Financial Highlights

For the quarter ended Dec 31, 2023, Kenvue posted revenue of $15.44B, down slightly from $14.95B in the prior quarter. Gross profit was $8.61B (margin 55.77%). Operating income was $2.94B (margin 19.0%). Net income was$1.66B (EPS $0.87).
The company ended the quarter with $1.38B in cash and short-term investments, a total debt of $8.43B, and net debt of $7.05B. Total assets were $27.85B, with equity of $11.21B. Financials further reflected stability, with operating cash flow of $3.17B, free cash flow of $2.70B, and capital expenditures of - $469.00M.

Price Forecast & Outlook

Our AI price prediction model suggests that Kenvue Inc. stock has strong potential for upside but may face short-term weakness followed by gains in the medium and long term. 2-Week Outlook: Projected increase of 0.96%, with price expected at $17.92 by September 23, 2026, within a range of $17.68 to $18.20 3-Month Outlook: Projected rise of 8.9%, reaching $19.33 by December 08, 2026, with a range of $18.46 to $20.21. 1-Year Outlook: Projected gain of 2.08%, with price at $18.12 by September 09, 2027, within a range of $17.37 to $18.92.

Key Takeaways

Kenvue Inc. (NYSE:KVUE) shares are flat 1.97% year-to-date currently trading near 52-week highs band. Short-term momentum has been positive over the last quarter, despite recent volatility. Valuation shows Kenvue Inc. trading at a premium to the broader market with a P/E of 20.44. Analyst sentiment is cautious, with the majority of ratings in Equal-Weight territory and a mean price target of $22.10, suggesting 24.51% upside. Our AI forecast model points to short-term strength (0.96% over two weeks), a medium-term rise (8.9% over three months), and a longer-term gain (2.08% over one year), with expected trading ranges indicating moderate volatility.

Frequently Asked Questions

What is the current Kenvue Inc. (KVUE) stock price?

Kenvue Inc. (NYSE: KVUE) stock price is $17.75 in the last trading session. During the trading session, KVUE stock reached the peak price of $18.23 while $17.67 was the lowest point it dropped to. The percentage change in KVUE stock occurred in the recent session was -3.48% while the dollar amount for the price change in KVUE stock was - $0.64.

KVUE's industry and sector of operation?

The NYSE listed KVUE is part of Household & Personal Products industry that operates in the broader Consumer Defensive sector. Kenvue Inc. designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.

Who are the executives of KVUE?

Ms. Kathleen M. Widmer
Group Pres of North America & Latin America
Ms. Ellie Bing Xie
Group Pres of Asia Pacific
Ms. Meredith Stevens
Chief Operations Officer
Ms. Heather R. Howlett
Chief Accounting Officer
Mr. Bernardo Tavares
Chief Data & Technology Officer
Dr. Caroline Tillett
Chief Scientific Officer
Mr. Matthew Orlando
Gen. Counsel
Mr. Paul Ruh
Chief Financial Officer
Mr. Carlton Lawson
Group Pres of Europe, Middle East & Africa

How KVUE did perform over past 52-week?

KVUE's closing price is 26.61% higher than its 52-week low of $14.02 where as its distance from 52-week high of $20.13 is -11.82%.

How many employees does KVUE have?

Number of KVUE employees currently stands at 21,890.

Link for KVUE official website?

Official Website of KVUE is: https://www.kenvue.com

How do I contact KVUE?

KVUE could be contacted at phone 908 874 1200 and can also be accessed through its website. KVUE operates from 1 Kenvue Way, Summit, NJ 07901, United States.

How many shares of KVUE are traded daily?

KVUE stock volume for the day was 22.52M shares. The average number of KVUE shares traded daily for last 3 months was 20.5M.

What is the market cap of KVUE currently?

The market value of KVUE currently stands at $34.08B with its latest stock price at $17.75 and 1.92B of its shares outstanding.

Employees	21890
Beta	0.43
Sales or Revenue	$15.44B
5Y Sales Change%	0.102%
Fiscal Year Ends	December
Sector	Consumer Defensive
Industry	Household & Personal Products

KVUE Company Profile and Key Details

Kenvue

Price Chart

Stock Price Today

Stock Snapshot

Relevant Articles

SEC Fillings

Current Report (8-k)

Annual Report (10-k)

Stock Price History Chart

Contact Details

About Company

Company Information

Stock Peers

Company Overview

Technical Performance

Valuation Metrics

Dividend & Fair Value

Earnings & Analyst Outlook

Shareholding & Insider Activity

Financial & Profitability Overview

Quarterly Financial Highlights

Price Forecast & Outlook

Key Takeaways

Frequently Asked Questions

Technical Performance

Financial & Profitability Overview

Quarterly Financial Highlights

Shareholding & Insider Activity

Earnings & Analyst Outlook

Company Overview

Dividend & Fair Value

Valuation Metrics

Key Takeaways

Price Forecast & Outlook